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Background:  Controlling  intracoronary  computed  tomography  (CT)  number  for coronary  CT  angiography
(CCTA)  has  been  difﬁcult.
Objective:  The  study  assessed  whether  intracoronary  CT  number  of CCTA  could  be  estimated.
Methods:  One  hundred  twenty  six  patients  were  randomly  assigned  to  either  CCTA  with  30  mL  of  contrast
media  (CM)  following  5 mL  of  CM  at timing  bolus  or CCTA  with  50 mL of  CM  following  10  mL  of  CM  at
timing  bolus.  The  relationships  between  intracoronary  CT  number  and  patients’  characteristics  and  peak
time  and  peak  CT  number  at timing  bolus  in  patients  who  showed  valid  time–density  curve  were  analyzed
in both  groups.  Then,  the  multiple  regression  equation  best  described  was  made.  The  prediction  system
was validated  by 112  patients  randomly  targeted  between  250  HU  and  430  HU  of CT  number.
Results:  In  group  5/30,  intracoronary  CT number  was positively  correlated  with  peak  CT  number  at  timing
bolus (correlation  coefﬁcient,  1.42,  p <  0.001),  negatively  correlated  with  body  surface  area  (−109.19,
p < 0.001)  and  peak  time  (−6.93,  p  < 0.001).  Whereas,  intracoronary  CT number  was  positively  correlated
with  only  peak  CT number  at timing  bolus  (1.33,  p <  0.001)  in  group  10/50.  Then,  CT  number-controlling
system  using  the simple  equation  best  described  CT  number  was  established  for  CCTA  following  5  mL  of
CM at  timing  bolus.  Of 112  patients,  there  was  good  correlation  between  target  CT  number  and  measured
CT number  (r  = 0.85, p < 0.0001)  in 96 patients  (85.7%),  having  valid  time–density  curve at  timing  bolus.
Conclusions:  Controlling  CT number  may  be enabled  by  CT  number-controlling  system  following  5  mL  of
© 20
CM at timing  bolus.
ntroduction
By the rapid improvement of multidetector row computed
omography (MDCT), CT coronary angiography (CCTA) has high
ccuracy [1] for detecting coronary artery disease with shorter scan
ime [2,3]. Shorter scan time may  potentially allow the performance
f CCTA with a lower amount of contrast material (CM) volume [4].
any protocols for CCTA have been proposed [5,6]. Recently, body
ass index (BMI)-adapted [7] and body surface area (BSA)-adapted
rotocols [8] have been proposed. However, intracoronary CT num-
er reported was quite high [4] and the ranges of CT number in
atients with a certain BMI  or BSA were too wide.
With a larger volume of CM,  the time–density curve (TDC) ﬂat-
ens [9].  Using this, the peak CT number may  be predictable by
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timing bolus. Therefore, the relationship between intracoronary CT
number and patients’ characteristics and peak time and peak CT
number were compared between two groups: CCTA with 30 mL  of
CM following 5 mL  of CM at timing bolus and CCTA with 50 mL  of
CM following 10 mL  of CM at timing bolus.
Then, CT number-controlling system using the simple equa-
tion best described CT number by multiple regression analysis was
established. Feasibility of the system was  examined by CCTA for
randomly targeting CT number.
Materials and methods
Study population
Two  hundred thirty eight consecutive patients who planned
to undergo CCTA were prospectively enrolled for the study. One
hundred twenty-six patients were enrolled for the test group. One
hundred twelve patients were enrolled for examining the feasibility
of CT-number-controlling system for a validation group.
ollege of Cardiology.
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Patients were referred because coronary artery disease was sus-
ected (n = 158) or known (n = 80). CCTA was indicated according
o the guideline [10].
First, 126 patients were randomly assigned to two  groups
Fig. 1).
Group 5/30 (n = 63): Timing bolus was performed with 5 mL  of CM.
CCTA was performed with 30 mL  of CM.
Group 10/50 (n = 63): Timing bolus was performed with 10 mL  of
CM.  CCTA was performed with 50 mL  of CM.
Saline chaser was 40 mL  and injection rate was 4 mL/s.
This study was approved by the local ethics committee, and
ll patients provided written informed consent. Clinical exclu-
ion criteria for CCTA were atrial ﬁbrillation, allergy to CM,  renal
nsufﬁciency (glomerular ﬁltration rate < 60 mL/min/1.73 mm2),
regnancy, congenital heart disease, low left ventricular function
ejection fraction less than 50%), or coronary artery bypass graft.
Patients were administered an oral beta-blocker (25 mg
tenolol, AstraZeneca, Osaka, Japan) 120 min  before and 0.3 mg  of
ublingual nitroglycerine 5 min  before CCTA. Patients’ heart rate
as controlled between 55 and 65 bpm by administering additional
ntravenous beta-blocker (2–10 mg  propranolol, AstraZeneca).
canning protocol
MDCT was performed using 64-detector CT scanner Lightspeed
CT (GE Healthcare, Milwaukee,WI, USA) with electrocardiogram
ECG) gating. Advantage Workstation 4.3 software (GE Healthcare)
as used. The scan sequence included scanogram, scout, timing
olus, and coronary angiography.
CCTA was performed with prospectively ECG triggered (Snap-
hot Pulse, GE Healthcare) with the following parameters: slice
cquisition, 64 mm × 0.625 mm (40-mm volume coverage); 75% of
he RR interval with 0–100 ms  of padding; rotation time, 350 ms;
emporal resolution, 175 ms;  tube potential, 120 kV; and tube cur-
ent, 450–680 mA.  If blurring artifact was found at timing bolus,
atients received CCTA with retrospective ECG gating. ECG modu-
ation of 40–80% of the RR interval was used because prospective
riggering had not been introduced. The pitch was approximately
.2–0.3.
CM (350 mgI/mL; Omnipaque 350; Daiichi Sankyo Pharmaceu-
ical Co., Ltd, Tokyo, Japan) was injected in a right antecubital
ein using a dual-headed injector system (Dual Shot GX, Nemoto
yorindo Co., Ltd, Tokyo, Japan) during the test injection and CCTA.
M (5 mL  or 10 mL)  was used as test injection for determining
he circulation time of the enhanced scan. Sequential scans were
btained every 2 s from 10 to 40 s after test injection. The region
f interest (ROI) was located in the ascending aorta, and a TDC was
etermined. The peak time was identiﬁed, and the absolute value
f CT number of the ascending aorta at the peak time was measured
t the ROI. Scan delay was deﬁned as 2 s after peak enhancement.
The validity of TDC was  deﬁned as follows: valid, TDC showing
 unimodal curve and in which the peak time and peak CT num-
er were measurable; invalid, TDC showing a ﬂat or multimodal
urve and/or in which the peak time and peak CT number were not
etermined.
elationship of CT number with patient characteristics and timing
olus parameters
The relationship of CT number with patient characteristics
nd timing bolus parameters was assessed in 63 patients who
nderwent CCTA in group 5/30 and group 10/50. Patients with
nvalid TDCs underwent CCTA using 0.7 mL/kg body weight of CM,
ut they were excluded from the study. Intracoronary CT numberiology 61 (2013) 155–161
was calculated as the mean value of vessel CT number in the left
main and proximal right coronary arteries after CCTA. Calciﬁcation,
plaques, and stents were carefully avoided.
Image quality of each patient was evaluated on a 5-point scale:
5 – excellent without blurring or stairstep artifact; 4 – very good
with slight artifacts; 3 – good and evaluable with artifacts; 2 – fair
and containing few unevaluable segments; and 1 – bad with 3 or
more unevaluable segments. The points in which two readers dis-
agreed were averaged. Interobserver agreement was evaluated by
the Kappa statistic.
Mean intracoronary CT number was  compared with age, height,
weight, body mass index (BMI) and body surface area (BSA), heart
rate, and the peak time and peak CT number on timing bolus
by univariate regression analysis and stepwise and multivariate
regression analyses.
Establishing CT number-controlling system
CCTA with ﬁxed dose of CM shows dynamic CT enhancement,
and peak CT enhancement is proportional to the amount of injected
CM [9].  The slope and intercept of a simple equation are measured
using 2 points:
(X, Y) = (DT, NT) and (DFD, NFD).
DT is the amount of CM at timing bolus; NT is the peak CT number
with CM during the timing bolus; DFD is the ﬁxed amount of CM at
coronary angiography; NFD is the estimated CT number with ﬁxed
dose of CM estimated by multilinear regression equation.
The amount of CM for targeted CT number was  estimated by the
simple equation using two points.
Validation of CT number-controlling system
A total of 112 consecutive patients underwent CCTA targeting
the vessel CT number between 250 HU and 430 HU, which was  ran-
domly assigned. Patients with invalid TDCs were excluded from the
study. Intracoronary CT number was calculated as the mean value
of vessel CT number in the left main and proximal right coronary
arteries after CCTA. Image quality of each patient was evaluated on
a 5-point scale described above.
Statistical analysis
Statistical analysis was  performed using SPSS 17.0 (SPSS Inc,
Chicago, IL, USA). Data were expressed as mean ± SD. CT num-
ber was compared with patient characteristics and timing bolus
parameters by using linear regression analysis and stepwise and
multivariate regression analyses. Correlation analysis was done
between target CT number and measured CT number by using lin-
ear regression analysis and analysis of agreement method by Bland
and Altman.
Results
Correlation of CT number with patient characteristics and
parameters
Patient characteristics of groups 5/30 and 10/50 are shown in
Table 1. Among 63 patients in group 5/30, 7 were excluded for
invalid TDCs. Among 63 patients in group 10/50, 11 were excluded
for invalid TDCs (Fig. 1). There was  no signiﬁcant difference in the
ratio of excluded patients between the two groups (p = 0.34). There
was no signiﬁcant difference in patients’ characteristics between
the two groups.
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Fig. 1. Disposition of patients in the test group.
Fig. 2. The relationship between peak time at timing bolus and peak computed tomography (CT) number in group 5/30 (A) and group 10/50 (B). (C) The relationship between
amount of contrast media and averaged intracoronary CT number. Points of 5 mL,  10 mL,  and 30 mL  of contrast media linearly correlated. Intracoronary CT number with
50  mL  of contrast media reached plateau.
158 S. Komatsu et al. / Journal of Cardiology 61 (2013) 155–161
Table 1
Clinical characteristics of the test group.
Group 5/30 10/50 p value
N 63 63 –
Gender male (n, %) 39(62) 40(63) 0.50
Age  (yo) 61 ± 15 59 ± 12 0.44
Height (cm) 161 ± 10 164 ± 7 0.97
Weight (kg) 62.1 ± 12.0 64.1 ± 8.9 0.33
BMI  (kg/m2) 23.5 ± 3.5 23.6 ± 3.5 0.86
BSA  (m2) 1.65 ± 0.19 1.68 ± 0.15 0.42
Risk  factors
Diabetes (n, %) 14 (22) 19(30) 0.55
Hyperlipidemia (n,  %) 42(67) 46(73) 0.83
Hypertension (n, %) 36 (57) 39(62) 0.87
Heart rate (bpm) 63 ± 6 58 ± 6 0.41
BMI, body mass index; BSA, body surface area.
Table 2
Parameters in the test scan and intracoronary CT number of CT coronary
angiography.
Group 5/30 10/50 p-Value
Peak time at timing bolus (s) 20 ± 3 20 ± 3 0.49
Peak CT number at timing
bolus (HU)
93 ± 20 137 ± 29 <0.0001
Contrast media per body
weight (mL/kg)
0.51 ± 0.10 0.80 ± 0.12 <0.0001
Intracoronary CT number (HU) 325 ± 70 373 ± 64 <0.0001
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Table 3B
Multivariate analysis of patients’ characteristics and parameters in the test scan
associated with intracoronary CT numbering group 5/30 and in group 10/50.
Variables Correlation Coefﬁcient
SE
p-Value 95% CI
Group 5/30
BSA −109.19 29.73 <0.0001 −168.93 to −49.46
Peak time −6.93 1.69 <0.0001 −10.34 to −3.53
Peak CT number 1.42 0.33 <0.0001 0.76–2.07
Constant 510.31 83.42 <0.0001 342.77–677.95
Group 10/50Image quality 4.6 ± 0.8 4.5 ± 0.9 0.30
T, computed tomography.
All scans were done successfully. In 46 of 56 patients (82%) of
roup 5/30 and 43 of 53 patients (81%) of group 10/50 CCTA was
erformed with prospective gating. Parameters and intracoronary
T number of CCTA are shown in Table 2. There were correlations
etween peak time at timing bolus and peak CT number at timing
olus in both groups (p = 0.53 and p = 0.47, respectively) in patients
ith valid TDC. The peak CT number at timing bolus was  higher in
roup 10/50 than that in group 5/30 (Fig. 2), however, there was no
igniﬁcant difference in test peak time (20 ± 3 s vs. 20 ± 3 s, p = 0.49)
nd image quality (4.6 ± 0.8 vs. 4.5 ± 0.9, p = 0.30) between the two
roups (Table 2). Kappa value was 0.89 in both groups.
Averaged intracoronary CT numbers with 5 mL,  10 mL,  and
0 mL  of CM were 93 HU, 137 HU, and 325 HU, respectively
Table 2). These three points linearly correlated (y = 9.31x + 45.3,
 = 0.99, p < 0.0001, Fig. 2C). The intracoronary CT number with
0 mL  of CM is predicted as 511 HU according to the dose-
ependent formula, but in fact, measured CT number with 50 mL
f CM was only 373 HU (Table 2).
The relationship of intracoronary CT number with patient char-cteristics and timing bolus parameters is shown in Table 3A.
n group 5/30, CT number at the timing bolus showed the
trongest positive correlation with CT number with 30 mL
able 3A
elationship among intracoronary CT number and patients’ characteristics and
arameters in the test scan.
Group 5/30 10/50
Parameters r p-Value r p-Value
Age 0.30 0.02 0.14 0.003
Height (cm) −0.61 <0.0001 −0.35 0.01
Weight (kg) −0.62 <0.0001 −0.38 0.005
BMI  (kg/m2) −0.41 <0.01 −0.19 0.18
BSA  (m2) −0.64 <0.0001 −0.41 0.002
Peak time (s) −0.65 <0.0001 −0.06 0.66
Peak CT number at
test scan (HU)
0.77 <0.0001 0.58 <0.0001
T, computed tomography; BMI, body mass index; BSA, body surface area.Peak CT number 1.33 0.32 <0.0001 0.68–1.98
CT, computed tomography; BSA, body surface area.
CM (r = 0.77, p < 0.0001). Height (r = −0.61, p < 0.0001), weight
(r = −0.62, p < 0.0001), BSA (r = −0.64, p < 0.0001), and peak time
(r = −0.65, p < 0.0001) showed signiﬁcant inverse correlations with
CT number. In group 10/50, CT number at the timing bolus showed
signiﬁcant positive correlation with CT number with 50 mL  CM
(r = 0.58, p < 0.0001). Height (r = −0.35, p = 0.01), weight (r = −0.38,
p = 0.005), and BSA (r = −0.41, p = 0.002) showed inverse correla-
tions with CT number. The best predictors of CT number with
30 mL CM were BSA (coefﬁcient −109.19, p < 0.0001), peak time
(−6.93, p < 0.0001), and peak CT number at the timing bolus (1.42,
p < 0.0001) (Table 3B).  In group 10/50, peak CT number at tim-
ing bolus was the only variable independently associated with CT
number (1.33, p < 0.0001).
Establishing CT number-controlling system by multiple regression
equation
As intracoronary CT numbers with 5 mL,  10 mL,  and 30 mL  of
CM linearly correlated, the following equation best described CT
number by group 5/30:
N30 : Estimated CT number with 30 mL  CM(HU)  = 1.42
× [CT number at the timing bolus with 5 mL  CM] − 109
× [BSA] − 6.93 × [peak time] + 510 (r = 0.84, p < 0.0001).
(1)
After the 5-mL test injection, CT number with 30 mL CM was
estimated by Eq. (1).
Then, two points were calculated.
(X, Y) = (D5, N5) and (D30, N30)
The slope and intercept of the equation for these 2 points were
determined, and the minimal amount of CM (D) for the targeted CT
number (N) was  estimated.
Validation of the CT number-controlling system for randomly
targeted CT number
One hundred twelve patients (64 male, 57%) aged 62 ± 14 years
(mean ± SD) were selected for the randomly targeted CT num-
ber between 250 HU and 430 HU. Height and weight averaged
160 ± 9 cm and 61 ± 10 kg, respectively. Sixteen patients (14.2%)
were excluded from the study because of invalid TDCs at the tim-
ing bolus. Averaged peak time was 19 ± 3 s and peak CT number
was 99 ± 20 HU in 96 patients. The amount of CM for CCTA was
average 26 ± 9 mL  (12–48 mL). All scans were done successfully. A
representative case is shown in Fig. 3. There was excellent corre-
lation between target and measured CT number (y = 1.00x, r = 0.85,
p < 0.0001) (Fig. 4A and B).
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Fig. 3. Representative case of 56-year-old woman. Height was 156 cm and weight was 49 kg. Peak time was  16 s and peak computed tomography (CT) number was  133 HU.
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iarget  CT number was  330 HU and measured CT number was 296 HU with 23 mL  of c
evel  of left main trunk. (C) Volume rendering image. (D) Angiographic view. (E) Cur
oronary artery. (G) Right coronary artery.
iscussionControlling CT number of CCTA may  have two advantages. The
ormer is that the invasiveness by CM may  be reduced by using min-
mum amount of CM.  The latter is that controlling CT number mayst media. Image quality was graded 5. (A) Time–density curve. (B) Axial image at the
ultiplanar reformation image of left anterior descending artery. (F) Left circumﬂex
play a role in quantitative analysis of coronary artery and plaque in
CT image.
Preventing contrast-induced nephropathy involves reducing
the given volume [11]. Initially, the peak CT number of TDC
grows dose-dependently according to pharmacokinetics of CM
160 S. Komatsu et al. / Journal of Card
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veasured CT number. There was  good correlation between target CT number and
easured CT number. y = 1.00x, r = 0.85, p < 0.0001. (B) Bland–Altman plot of the
ame data.
9].  As injection volume increases, the growth rate of the peak
T number of TDC reduces and TDC broaden and become more
symmetric [9]. Scan time of MDCT has shortened as a result of
mprovements in temporal resolution. Thus, shorter duration of the
eak of coronary CT number is enough for 64-row MDCT [12] or
ore.
Although many protocols [5] changed the infusion rate, our pro-
ocol ﬁxed the infusion rate as 4 mL/s. On the other hand, according
o our preliminary measurement by ultrasonography, the ﬂow rate
f right subclavian vein and superior vena cava were tens of times
igher, showing approximately 90 mL/s and 200 mL/s, respectively
data not shown). The protocol of ﬁxed infusion rate may  make the
ondition simple avoiding the potential difference of the circulation
ime of CM and CT number. Saline chaser may  reduce the contrast
aterial volume [13]. Saline chaser might effectively wash out 5 mL
f CM as well as 10 mL  of CM in infused vein to main venous ﬂow,
robably washing out trapped CM by venous valve. There was  no
ifference in peak time of test injection between group 5/30 and
roup 10/50. There was also no difference between the ratio of valid
DC between group 5/30 and group 10/50. The result showed that
he dose of CM was not the cause of invalid TDC. Timing bolus with mL  of CM is comparable to that with 10 mL  of CM.  It is speculated
hat invalid TDC is due to obstacles caused by heart beat or venous
irculation, for example, arrhythmia, valve regurgitation, or venous
olume.iology 61 (2013) 155–161
In multivariate analysis, the best predictors of CT number with
30 mL CM were BSA, peak time, and CT number at the timing bolus
in group 5/30, whereas peak CT number at timing bolus was the
only variable in group 10/50. In univariate analysis, there was a
stronger relationship between CT number and peak CT number at
timing bolus in group 5/30 than those in group 10/50. Thus, mul-
tiple regression equation in group 5/30 was thought to be more
accurate than that in group 10/50. Intracoronary CT number of
30 mL of CM may  be predicted from BSA, peak time, and CT number
at the timing bolus with 5 mL  of CM.  Furthermore, good corre-
lation between target CT number and measured CT number was
obtained with minimum amount of CM by using the proportional
formula through (D5, N5) and (D30, N30). Averaged intracoronary
number with 5 mL,  10 mL,  and 30 mL  of CM were linearly corre-
lated to the amount of CM.  Intracoronary CT number with 50 mL
was not correlated, suggesting that 50 mL  of CM might reach the
plateau of CT number. The threshold of CM, in other words, the
maximum amount of CM which shows dose-dependent CT num-
ber before plateau, seems to be important for effective usage of CM.
That might be determined by measuring intracoronary CT number
after CM injection of several volumes, such as 20, 30, 40, and 50 mL
of CM.  We  already know that we  only need 12–48 mL  of CM for
CCTA. Obviously, the trial of repetitive CCTA with too much CM
raises ethical problems including radiation. Averaged intracoro-
nary CT number ranged 250–400 HU for CCTA with 30 mL  of CM
(Fig. 2C). Intracoronary CT number showed 325 ± 70 HU in group
5/30 (Table 2). SCCT guideline mentioned that intracoronary CT
number should be 250 HU or more. These results show that 30 mL
of CM might be within the threshold of CM and it is not indispens-
able to calculate what amount of CM comes to plateau for each
patient.
CCTA may  detect plaque components with CT numbers [14–16].
Scattered CT number has long been a major problem for the quali-
tative and quantitative analysis of MDCT. CT number and diameter
are not reliable, with different CT numbers [17]. The most inﬂu-
ential is the CT number of the coronary lumen. High CT number
may  amplify plaque CT number [18], decrease plaque detectabil-
ity [19] and result in overestimation of soft plaque density [20].
CT number of CCTA was recommended to be at least 250 HU [10].
Three hundred ﬁfty HU was thought to be the best CT number
for analyzing plaques [17]. Therefore, random targets of CT num-
ber showed excellent correlation by CT number-controlling system
covered 250 HU and 350 HU. The optimized CT number of coronary
arteries and plaques may  potentially enable us to more quantita-
tively diagnose whether a plaque has regressed or progressed by
the change in CT number of the plaque.
Study limitations
CT number-controlling system might be difﬁcult to apply in
patients with low left ventricular function, congenital heart disease,
and valve regurgitation because the reaching time of CM might be
extended and peak CT number become lower. Physique of patients
was typical for Asians but might be smaller than that in Western-
ers. As the prediction of CT number by CT number-controlling is
based on venous pharmacokinetics, CT number-controlling system
might be applied to other machines with shorter scan time than 64-
row CT, however, CT number-controlling system is not validated for
other CT apparatus yet. The CT number-controlling system is valid
in cases with 350 mgI/mL of iodine concentration. Whether this
optimized contrast enhancement with the CT number-controlling
system would provide more reasonable cost/effect outcomes for
the evaluation of stenosis and plaque characteristics than the cur-
rent standards in CCTA should be addressed in future.
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The CT number-controlling system can control CT number in
CTA with small amounts of CM.  Clinical application may  involve
ower invasive CCTA with low doses of CM.
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